Literature DB >> 17129787

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.

Hosein Kouros-Mehr1, Euan M Slorach, Mark D Sternlicht, Zena Werb.   

Abstract

The GATA family of transcription factors plays fundamental roles in cell-fate specification. However, it is unclear if these genes are necessary for the maintenance of cellular differentiation after development. We identified GATA-3 as the most highly enriched transcription factor in the mammary epithelium of pubertal mice. GATA-3 was found in the luminal cells of mammary ducts and the body cells of terminal end buds (TEBs). Upon conditional deletion of GATA-3, mice exhibited severe defects in mammary development due to failure in TEB formation during puberty. After acute GATA-3 loss, adult mice exhibited undifferentiated luminal cell expansion with basement-membrane detachment, which led to caspase-mediated cell death in the long term. Further, FOXA1 was identified as a downstream target of GATA-3 in the mammary gland. This suggests that GATA-3 actively maintains luminal epithelial differentiation in the adult mammary gland, which raises important implications for the pathogenesis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17129787      PMCID: PMC2646406          DOI: 10.1016/j.cell.2006.09.048

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  45 in total

Review 1.  Hematopoietic development: a balancing act.

Authors:  A B Cantor; S H Orkin
Journal:  Curr Opin Genet Dev       Date:  2001-10       Impact factor: 5.578

Review 2.  Anoikis mechanisms.

Authors:  S M Frisch; R A Screaton
Journal:  Curr Opin Cell Biol       Date:  2001-10       Impact factor: 8.382

Review 3.  Hormonal and local control of mammary branching morphogenesis.

Authors:  Mark D Sternlicht; Hosein Kouros-Mehr; Pengfei Lu; Zena Werb
Journal:  Differentiation       Date:  2006-09       Impact factor: 3.880

4.  Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice.

Authors:  K U Wagner; K McAllister; T Ward; B Davis; R Wiseman; L Hennighausen
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

5.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

6.  Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.

Authors:  A R Utomo; A Y Nikitin; W H Lee
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

7.  Genetic mosaic analysis reveals that GATA-4 is required for proper differentiation of mouse gastric epithelium.

Authors:  Christina M Jacobsen; Naoko Narita; Malgorzata Bielinska; Andrew J Syder; Jeffrey I Gordon; David B Wilson
Journal:  Dev Biol       Date:  2002-01-01       Impact factor: 3.582

8.  Predicting the clinical status of human breast cancer by using gene expression profiles.

Authors:  M West; C Blanchette; H Dressman; E Huang; S Ishida; R Spang; H Zuzan; J A Olson; J R Marks; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

9.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

Authors:  S Gruvberger; M Ringnér; Y Chen; S Panavally; L H Saal; M Fernö; C Peterson; P S Meltzer
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

10.  Gene expression profiling of primary breast carcinomas using arrays of candidate genes.

Authors:  F Bertucci; R Houlgatte; A Benziane; S Granjeaud; J Adélaïde; R Tagett; B Loriod; J Jacquemier; P Viens; B Jordan; D Birnbaum; C Nguyen
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

View more
  292 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

Review 2.  The difficulty of targeting cancer stem cell niches.

Authors:  Mark A LaBarge
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.

Authors:  Marie-Liesse Asselin-Labat; Kate D Sutherland; François Vaillant; David E Gyorki; Di Wu; Sheridan Holroyd; Kelsey Breslin; Teresa Ward; Wei Shi; Mary L Bath; Siddhartha Deb; Stephen B Fox; Gordon K Smyth; Geoffrey J Lindeman; Jane E Visvader
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 4.  Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.

Authors:  Tanya V Kalin; Vladimir Ustiyan; Vladimir V Kalinichenko
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

Review 5.  Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.

Authors:  Shannon L Kelleher; Nicholas H McCormick; Vanessa Velasquez; Veronica Lopez
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

6.  The Gata3 transcription factor is required for the survival of embryonic and adult sympathetic neurons.

Authors:  Konstantina Tsarovina; Tobias Reiff; Jutta Stubbusch; Dorota Kurek; Frank G Grosveld; Rosanna Parlato; Günther Schütz; Hermann Rohrer
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

7.  Higher levels of GATA3 predict better survival in women with breast cancer.

Authors:  Nam K Yoon; Erin L Maresh; Dejun Shen; Yahya Elshimali; Sophia Apple; Steve Horvath; Vei Mah; Shikha Bose; David Chia; Helena R Chang; Lee Goodglick
Journal:  Hum Pathol       Date:  2010-12       Impact factor: 3.466

8.  Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.

Authors:  Kyueng-Whan Min; Dong-Hoon Kim; Sung-Im Do; Seoung Wan Chae; Kyungeun Kim; Jin Hee Sohn; Jung-Soo Pyo; Hyun Joo Lee; Dong Hyun Kim; Sukjoong Oh; Seon Hyeong Choi; Yong Lai Park; Chan Heun Park; Eun-Kyung Kim; Mi Jung Kwon; Jinwon Seo; Kyoung Min Moon
Journal:  Virchows Arch       Date:  2015-12-30       Impact factor: 4.064

Review 9.  Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer.

Authors:  Christina N Bennett; Jeffrey E Green
Journal:  Toxicol Pathol       Date:  2010-01-15       Impact factor: 1.902

10.  JARID1B is a luminal lineage-driving oncogene in breast cancer.

Authors:  Shoji Yamamoto; Zhenhua Wu; Hege G Russnes; Shinji Takagi; Guillermo Peluffo; Charles Vaske; Xi Zhao; Hans Kristian Moen Vollan; Reo Maruyama; Muhammad B Ekram; Hanfei Sun; Jee Hyun Kim; Kristopher Carver; Mattia Zucca; Jianxing Feng; Vanessa Almendro; Marina Bessarabova; Oscar M Rueda; Yuri Nikolsky; Carlos Caldas; X Shirley Liu; Kornelia Polyak
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.